Fluzone High-Dose: Clinical Trials

7 trials of Fluzone High-Dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Active not recruiting 1, Not yet recruiting 1, Unknown 1

Follow Fluzone High-Dose: new trials by email Literature Review of Fluzone High-Dose trials Research Report on Fluzone High-Dose

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity of Standard-Dose Versus High-Dose Influenza Vaccines in Older Adults in Singapore
High-dose influenza vaccine, Standard-dose influenza vaccine - Influenza
Phase 4Not yet recruitingTan Tock Seng Hospital1502026-11-012026-10-20
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
Fluzone, Flucelvax, Fluzone High-Dose - Influenza
Phase 4Active not recruitingUniversity of Alabama at Birmingham502021-04-012026-05-14
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine - Plasma Cell Neoplasm
Phase 4CompletedEmory University1652019-10-182025-02-28
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
Flublok, Flucelvax, Fluarix - Influenza
Phase 4CompletedCenters for Disease Control and Prevention9442018-09-122024-07-22
Gene Signatures of Influenza Vaccine Responses in Older Adults
Fluad Vaccine, Fluzone High-Dose - Influenza
Phase 4CompletedMayo Clinic2412018-08-272023-05-16
Duration of Immune Response to Influenza Vaccination in Patients With RA
Influenza vaccine - Rheumatoid Arthritis
Phase 4CompletedBassett Healthcare872014-08-012017-01-06
High-Dose Influenza Vaccine in Nursing Homes
HD Vaccine, SD Vaccine, Free Vaccine - Influenza
Phase 4UnknownInsight Therapeutics, LLC8232013-02-012018-07-16

Conditions studied

Influenza, Human (5)  ·  Arthritis, Rheumatoid (1)  ·  Neoplasms, Plasma Cell (1)

Sponsors

Bassett Healthcare (1)  ·  Centers for Disease Control and Prevention (1)  ·  Emory University (1)  ·  Insight Therapeutics, LLC (1)  ·  Mayo Clinic (1)  ·  Tan Tock Seng Hospital (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (6)  ·  Singapore (1)

Top investigators

Barnaby E Young, MB BChir, PhD (1)  ·  Brendan Flannery, PhD (1)  ·  Craig Hofmeister, MD, MPH (1)  ·  Donald Raddatz, MD (1)  ·  Ed Davidson, PharmD, MPH (1)  ·  Fatimah Dawood, MD (1)  ·  James J Kobie, PhD (1)  ·  Richard B Kennedy (1)  ·  Stefan Gravenstein, MD, MPH (1)  ·  Vincent Mor, PhD (1)

Results publications

PMID 26908539, PMID 28736045, PMID 34245243, PMID 36031405, PMID 38177116

NIH funding

P30CA138292 (1), R01AI132348 (1)